Company Abattis Bioceuticals Corp. Canadian Securities Exchange
Equities
ATT
CA00258G1037
Healthcare Facilities & Services
Business Summary
Sales per Business
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Cannabis Flower and Oils
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +4,024.17% |
Sales per region
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Netherlands
97.8
%
| - | - | 0 | 97.8 % | - |
Canada
2.2
%
| 0 | 100.0 % | 0 | 2.2 % | -8.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 19-03-31 | |
Patrick Mitchell
COO | Chief Operating Officer | - | 18-10-31 |
Jonathan Danieli
IRC | Investor Relations Contact | - | - |
Corporate Secretary | - | 18-09-10 | |
Shawn Balaghi
PRN | Corporate Officer/Principal | - | 18-05-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cedric Wilson
BRD | Director/Board Member | - | 18-10-18 |
Patrick Mitchell
COO | Chief Operating Officer | - | 18-10-31 |
Director of Finance/CFO | - | 19-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 479,554,139 | 477,804,139 ( 99.64 %) | 1,750,000 ( 0.3649 %) | 99.64 % |
Company contact information
Abattis Bioceuticals Corp.
625 Howe Street Suite 1200
V6C 2T6, Vancouver
+808 650 3007
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+31.96% | 264M | |
+33.74% | 251M | |
+49.42% | 193M | |
+44.98% | 125M | |
-42.17% | 122M | |
-28.57% | 121M | |
+115.91% | 120M | |
0.00% | 83.42M | |
+150.00% | 75.33M |